Heart Transplantation: A Review of Evolution, Current Status, and Persistent Challenges

Read full text Summarise with VIRAT
Authors: China E Stegall, Chand Ramaiah, Kemal Marc Akat
Cited by: 0
References: 56

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Heart transplantation (HTx) remains the gold-standard therapy for select patients with end-stage heart failure, offering significant improvements in survival and quality of life. Since its clinical introduction in 1967 in South Africa by Christiaan Barnard, advancements in surgical techniques, immunosuppressive regimens, and posttransplant care have improved 1-year survival rates from 81% before the year 2000 to over 90%. However, long-term survival is still limited by formidable complications such as chronic rejection, most notably cardiac allograft vasculopathy, malignancy, and the nephrotoxic effects of chronic immunosuppression. This review outlines the historical milestones, current clinical practice, including patient selection and immunosuppression, and discusses the major challenges that continue to drive research in the field.

Fields of Study & Subjects

Transplantation: Methods and Outcomes Organ and Tissue Transplantation Research Organ Transplantation Techniques and Outcomes

Publication details

Journal / source
International Journal of Angiology
Volume
35
Issue
04
Pages
314–321
Publication date
20 March 2026
Language
EN